Side-by-side comparison of AI visibility scores, market position, and capabilities
JUST Egg plant-based egg brand and GOOD Meat cultivated chicken pioneer; raised $800M+ total, USDA-approved cultivated chicken in commercial sale since 2023.
Eat Just, Inc. is a San Francisco-based food technology company founded in 2011 by Josh Tetrick and Josh Balk. The company operates two distinct businesses: JUST Egg, a mung bean-based liquid egg substitute that is the leading plant-based egg brand in the US; and GOOD Meat, its cultivated meat division that produces chicken from animal cells without slaughter.\n\nGOOD Meat became one of the first two US companies to receive USDA approval to sell cultivated chicken in June 2023, alongside Upside Foods, representing a historic regulatory milestone. JUST Egg has achieved significant commercial scale, selling over 100 million JUST Egg bottles in the US and in over 40 countries. The brand is available at Whole Foods, Walmart, Costco, and thousands of other retailers. Eat Just has raised over $800 million in total funding from SoftBank, Li Ka-shing's Horizons Ventures, and other strategic investors.\n\nThe company operates distinct distribution operations for JUST Egg and GOOD Meat, with the latter focused on high-end food service given the early-stage production economics of cultivated meat. The dual-track approach — a scaled consumer brand in JUST Egg and an early-stage cultivated meat program in GOOD Meat — makes Eat Just one of the most diverse alternative protein platforms.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.